FDA Makes Safety Labeling Changes
The Carlat Addiction Treatment Report, Volume 1, Number 3, November 2013
https://www.thecarlatreport.com/newsletter-issue/catrv1n3/
Issue Links: Learning Objectives | Editorial Information
Topics: Addiction | News of Note
In September, the US Food and Drug Administration (FDA) proposed safety labeling changes for extended-release and long-acting (ER/LA) opioid analgesics intended to treat pain.
You can't view details of this content, please login or buy subscription here